Patient Safety & Clinical Risk Management

Welcome to the last article in our series on medication nonadherence. We’ve examined the scope of the problem; looked at several ways physicians and health care providers can reduce the incidence of nonadherence; and addressed the key role played by the pharmacological community. If you’ve been following along the entire time, thank you! However, you might understandably be wondering, do these interventions actually work? Studies have shown that certain medication adherence interventions do work.

Welcome back! This is the sixth post in a series exploring the various problems posed by medication nonadherence. So far, we’ve discussed the scope of the problem and its impact, as well as a few ways that physicians and can tackle this growing challenge using both market based solutions and strategic remedies. Today, we turn our attention to the men and women on the front lines, the people literally put the medication in the patient’s hands: pharmacists.

While governments and markets can offer strategies and incentives for patients to take their medication, there are some quick and easy steps that physicians can take to address the problem right in the doctor’s office. In this article, the fifth in our continuing series on medication nonadherence, we’ll discuss some of those steps and how they work.

The overall strategy revolves around sharpening communication skills and consists of three components: First, monitoring adherence; second, promoting adherence; and third, providing effective interventions.

Welcome to the fourth article in our series exploring the scope and impact of medication nonadherence. This week, we will focus on government- and market-based strategies to improve medication management and adherence.

The stakeholders in this effort are numerous: patients; health care professionals; federal, state, and local governmental agencies; policy makers; third-party payers: private insurers; independent consumer groups and nonprofits; pharmaceutical companies and other commercial interests, such as those who make medication-adherence products.

The answer to the title question is, "It’s complicated" — because for most patients, there is not one unique and distinct reason for nonadherence, nor is there one simple solution for correcting it.

The complexity of this issue was detailed last year in a New York Times health blog post by Danielle Ofri, MD. Dr. Ofri, a New York City internist with a PhD in pharmacology, recounted what it would take for a 67-year-old patient who has diabetes, hypertension, and high cholesterol to be entirely adherent to all medical recommendations.

Pages